TNFSF10 and cancer: TRAIL also affects non-cancer cell viability and activity, such as thymocytes (119), neural cells (120), hepatocytes (121), osteoclasts (122, 123), stem cells (124), valvular interstitial cells (125, 126), vascular smooth muscle cells (127), and osteoblasts (128–130).